P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood–brain barrier: evidence from microdialysis experiments in rats
- 8 May 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 327 (3) , 173-176
- https://doi.org/10.1016/s0304-3940(02)00423-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic DrugsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Selective modulation of P-glycoprotein-mediated drug resistanceBritish Journal of Cancer, 2001
- In Vivo Evidence for P‐Glycoprotein–Mediated Transport of Phenytoin at the Blood–Brain Barrier of RatsEpilepsia, 2001
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- P-Glycoprotein, a gatekeeper in the blood–brain barrierAdvanced Drug Delivery Reviews, 1999
- Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsyThe Lancet, 1995
- MDR1 Gene Expression in Brain of Patients with Medically Intractable EpilepsyEpilepsia, 1995
- FelbamateDrugs, 1993
- Pharmacokinetic Optimisation of Anticonvulsant TherapyClinical Pharmacokinetics, 1992
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983